$CXApp (CXAI.US)$ CXApp (NASDAQ:CXAI) reported quarterly losses of $(0.29) per share which missed the analyst consensus estimate of $(0.24) by 20.83 percent. The company reported quarterly sales of $1.897 million which beat the analyst consensus estimate of $1.800 million by 5.39 percent. This is a 7.18 percent increase over sales of $1.770 million the same period last year.

$FOCUS (0116.MY)$ is this stock easy to sell out??

$ARMADA (5210.MY)$
if support works, let's monitor possible breakout resistance?

$CXApp (CXAI.US)$ when those large caps get up too high money will flow into mid and small caps stocks because they will be looking for bargains

$TC BioPharm (TCBP.US)$  only reason its down is because of the shorting and distorting. i am up to over 25k shares buying these dips.

$Rallybio (RLYB.US)$ Reuters· just
Rallybio Announces Approval of Clinical Trial Applications for Phase 2 Trial of Rlyb212 in Pregnant Women at Higher Risk of Alloimmunization and Fnait

$TC BioPharm (TCBP.US)$ squeeze the shorts